GlobalData provides unique and market-leading data and insights into the central nervous system market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Postherpetic Neuralgia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021" provides an overview of Postherpetic Neuralgia Clinical trials scenario. This report provides top line data relating to...

Alcohol Addiction – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Alcohol Addiction - Global Clinical Trials Review, H2, 2021" provides an overview of Alcohol Addiction Clinical trials scenario. This report provides top line data relating to...

Friedreich Ataxia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Friedreich Ataxia - Global Clinical Trials Review, H2, 2021" provides an overview of Friedreich Ataxia Clinical trials scenario. This report provides top line data relating to...

Fibromyalgia (Fibromyalgia Syndrome) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Fibromyalgia (Fibromyalgia Syndrome) - Global Clinical Trials Review, H2, 2021" provides an overview of Fibromyalgia (Fibromyalgia Syndrome) Clinical trials scenario. This report provides top line data...

Migraine – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Migraine - Global Clinical Trials Review, H2, 2021" provides an overview of Migraine Clinical trials scenario. This report provides top line data relating to the clinical...

Bipolar Disorder (Manic Depression) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Bipolar Disorder (Manic Depression) - Global Clinical Trials Review, H2, 2021" provides an overview of Bipolar Disorder (Manic Depression) Clinical trials scenario. This report provides top...

Cerebral Palsy – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Cerebral Palsy - Global Clinical Trials Review, H2, 2021" provides an overview of Cerebral Palsy Clinical trials scenario. This report provides top line data relating to...

Dementia – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Dementia - Global Clinical Trials Review, H2, 2021" provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical...

Autism – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Autism - Global Clinical Trials Review, H2, 2021" provides an overview of Autism Clinical trials scenario. This report provides top line data relating to the clinical...

Migraine Drug Market Size, Share & Trends Analysis and Forecast by Strategic Competitor Assessment, Market Characterization, Unmet Needs, Clinical Trial Mapping and Implications 2020 – 2030

  • $10,995
  • November 2021
Migraine is a complex neurological condition characterized by frequent headaches that can last between four and 72 hours. The pain is often unilateral and pulsating in nature, which can often...